Assistant Professor, Laboratory Medicine, U of WA Sch of Med

Pathology

Dr. Min Xu is an expert in the field of Pathology. He attended Beijing Medical University. has written publications. He has 21 publications published with PubMed. The lastest publication is: 'The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells.'

Publications

---

• Novel strategy to decrease reperfusion injuries and improve function of cold-preserved livers using normothermic ex vivo liver perfusion machine.
• Regulation of androgen receptor splice variant AR3 by PCGEM1.
• Severe combined immunodeficiency (SCID) presenting with neonatal aplastic anemia.
• Minor dehydrogenated and cleavaged dammarane-type saponins from the steamed roots of Panax notoginseng.
• Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines.
• Meta-analysis of genome-wide association studies of adult height in East Asians identifies 17 novel loci.
• Phenyl-1-pyridin-2yl-ethanone (PPY)-based Iron Chelators Increase IKBα Expression, Modulate CDK2 and CDK9 activities and Inhibit HIV-1 Transcription.
• Role of the lncRNA-p53 regulatory network in cancer.
• Chlamydia psittaci exposure in pet birds.
• The Hypoxic Response Contributes to Altered Gene Expression and Pre-Capillary Pulmonary Hypertension in Patients with Sickle Cell Disease.
• Multi-scale geospatial agroecosystem modeling: A case study on the influence of soil data resolution on carbon budget estimates.
• Negative regulation of lncRNA GAS5 by miR-21.
• Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing.
• Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.
• Chronic myelogenous leukemia presenting in blast crisis with nodal, bilineal myeloid sarcoma and T-lymphoblastic lymphoma in a child.
• Preclinical evaluation of Mab CC188 for ovarian cancer imaging.
• HIV-1 Resistant CDK2-Knockdown Macrophage-Like Cells Generated from 293T Cell-Derived Human Induced Pluripotent Stem Cells.
• Individualized Supplementation of Folic Acid According to Polymorphisms of Methylenetetrahydrofolate Reductase (MTHFR), Methionine Synthase Reductase (MTRR) Reduced Pr...
• Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1).
• The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells.

Doctors Specialties

---

• Clinical Pathology
• Pathology

Accepted Insurances

---

• Choice Plus POS II
• Blue Card PPO
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Commercial Insurance Company
• First Choice Health
• Group Health Cooperative
• Medicaid
• Medicare MCR
• Molina
• ODS Health Plan
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO

Education

---

• George Washington University
• Beijing Medical University

Hospital

---

• Seattle Children's Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Peter M. Benda, MD This Doctor is OpenDoctor Recommended.
	Dr. Donald R. Howard, MD This Doctor is OpenDoctor Recommended.
	Dr. Shane S. Anderson, MD This Doctor is OpenDoctor Recommended.
	Dr. Brad T. Cookson, MD
	Dr. Paul F. Edmonson, MD This Doctor is OpenDoctor Recommended.
	Dr. Noah G. Hoffman, MD This Doctor is OpenDoctor Recommended.
	Dr. David H. Dail, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew N. Hoofnagle, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Keith R. Jerome, MD
	Dr. David M. Sherer, MD This Doctor is OpenDoctor Recommended.
	Dr. David Chou, MD
	Dr. Yap-Yee Chong, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark R. Kilgore, MD This Doctor is OpenDoctor Recommended.
	Dr. Adam J. Saenz, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog